These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22440750)

  • 21. Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
    Fox MP; McKinlay MA; Diana GD; Dutko FJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1040-7. PubMed ID: 1656851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization.
    Katpally U; Fu TM; Freed DC; Casimiro DR; Smith TJ
    J Virol; 2009 Jul; 83(14):7040-8. PubMed ID: 19403680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical stiffening of human rhinovirus by cavity-filling antiviral drugs.
    Valbuena A; Rodríguez-Huete A; Mateu MG
    Nanoscale; 2018 Jan; 10(3):1440-1452. PubMed ID: 29302674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
    Shepard DA; Heinz BA; Rueckert RR
    J Virol; 1993 Apr; 67(4):2245-54. PubMed ID: 8383239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
    Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
    J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structure of human rhinovirus 16.
    Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
    Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses.
    Hendry E; Hatanaka H; Fry E; Smyth M; Tate J; Stanway G; Santti J; Maaronen M; Hyypiä T; Stuart D
    Structure; 1999 Dec; 7(12):1527-38. PubMed ID: 10647183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
    Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
    J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel benzonitrile analogue inhibits rhinovirus replication.
    Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.
    Badger J; Minor I; Kremer MJ; Oliveira MA; Smith TJ; Griffith JP; Guerin DM; Krishnaswamy S; Luo M; Rossmann MG
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3304-8. PubMed ID: 2835768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides.
    Ninomiya Y; Shimma N; Ishitsuka H
    Antiviral Res; 1990 Feb; 13(2):61-74. PubMed ID: 2160796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labeling of capsid proteins and genomic RNA of human rhinovirus with two different fluorescent dyes for selective detection by capillary electrophoresis.
    Kremser L; Petsch M; Blaas D; Kenndler E
    Anal Chem; 2004 Dec; 76(24):7360-5. PubMed ID: 15595880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capsid structure and dynamics of a human rhinovirus probed by hydrogen exchange mass spectrometry.
    Wang L; Smith DL
    Protein Sci; 2005 Jun; 14(6):1661-72. PubMed ID: 15883190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.
    Rossmann MG
    Antiviral Res; 1989 Feb; 11(1):3-13. PubMed ID: 2540708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.
    Rollinger JM; Schmidtke M
    Med Res Rev; 2011 Jan; 31(1):42-92. PubMed ID: 19714577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A.
    Vaidehi N; Goddard WA
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2466-71. PubMed ID: 9122218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses.
    Laine P; Savolainen C; Blomqvist S; Hovi T
    J Gen Virol; 2005 Mar; 86(Pt 3):697-706. PubMed ID: 15722530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human rhinovirus 3 at 3.0 A resolution.
    Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
    Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins.
    Mosser AG; Shepard DA; Rueckert RR
    Arch Virol Suppl; 1994; 9():111-9. PubMed ID: 8032243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.